Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients

BACKGROUND: The Japan Guidelines of Lung Cancer Therapy recommend epidermal growth factor receptor-tyrosine kinase inhibitors as a first-line therapy for advanced/recurrent non-small cell lung cancer patients with epidermal growth factor receptor mutation. Although survival periods in recent reports...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Jpn J Clin Oncol
Main Authors: Inoue, Akira, Yoshida, Kazushi, Morita, Satoshi, Imamura, Fumio, Seto, Takashi, Okamoto, Isamu, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Muto, Satoshi, Fukuoka, Masahiro
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4874470/
https://ncbi.nlm.nih.gov/pubmed/26977054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyw014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados